Hepion Pharmaceuticals Inc (HEPA) Live Share Price, Invest From India

Hepion Pharmaceuticals Inc Stock Performance

as on March 3, 2026 at 2:41 am IST

Day's Low
Day's High
$0.32
Day's Price Range
$0.32
$0.03
-966.67%
Downside
966.67%
Upside
52 Week's Low
52 Week's High
$0.25
52-Week Price Range
$0.75
$0.03
-733.33%
Downside
2388.00%
Upside

Hepion Pharmaceuticals Inc share price movements today

Previous Close: $0.14
Open: $0.32
Volume: 2.1K
Day's Low - High: $0.32 - $0.32
52 Week Low - High: $0.25 - $0.75

Hepion Pharmaceuticals Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Hepion Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Hepion Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Hepion Pharmaceuticals Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Hepion Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Hepion Pharmaceuticals Inc	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Hepion Pharmaceuticals Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Hepion Pharmaceuticals Inc. Average target price of $30

Hepion Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Hepion Pharmaceuticals Inc.

What analysts predicted

99.9%UPSIDE

Target Price

$30

Current Price

$0.03

Analyzed by

8 Analysts

Target

$30.00

Hepion Pharmaceuticals Inc target price $30, a slight upside of 99.9% compared to current price of $0.03. According to 8 analysts rating.

Hepion Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Total Revenue	-	-	-	-	-	0	-	-	-
Gross Profit	-	0	0	0	-	0	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-6	-13	-14	-10	-11	-2	-3	-4	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-2600.75%	0.00%	0.00%	0.00%

Hepion Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-14	-16	-9	-7	-20	-32	-42	-48	-13
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Hepion Pharmaceuticals Inc

Funds	Holdings
Anson Funds Management LP	0.43%
BlackRock Inc	0.15%
Vanguard Group Inc	0.09%
Geode Capital Management, LLC	0.08%
Susquehanna International Group, LLP	0.05%

See all

About Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on artificial intelligence (AI)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (NASH), fibrotic diseases, hepatocellular carcinoma (HCC), and other chronic diseases. Its primary asset, Rencofilstat, is a potent inhibitor of cyclophilins, which are involved in many disease processes. Rencofilstat reduces liver fibrosis and hepatocellular carcinoma tumor burden in experimental disease models. Its drug candidate is intended to target multiple molecular pathways across the full spectrum of liver disease progression, from the triggering events that initiate disease to the pathological events that directly impair liver function and integrity. Its AI-POWR platform provides integrative, multi-variate, systems-biology bioinformatic and big-data analysis of proprietary pre-clinical and clinical data with publicly available multi-omic databases.

Organisation	Hepion Pharmaceuticals Inc
E-voting on shares	Click here to vote

FAQs

What is Hepion Pharmaceuticals Inc share price today?

Hepion Pharmaceuticals Inc share price today is $0.03 as on March 2, 2026 at 9:11 pm IST at the close of the market. Hepion Pharmaceuticals Inc share today touched a day high of $0.32 and a low of $0.32.

What is the 52 week high and 52 week low for Hepion Pharmaceuticals Inc share?

Hepion Pharmaceuticals Inc share touched a 52 week high of $0.75 on April 9, 2025 and a 52 week low of $0.25 on April 22, 2025. Hepion Pharmaceuticals Inc stock price today i.e. March 2, 2026 at 9:11 pm IST is closed at $0.03,which is 95.98% down from its 52 week high and -88.00% up from its 52 week low.

How to invest in Hepion Pharmaceuticals Inc Stock (HEPA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Hepion Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hepion Pharmaceuticals Inc Shares that will get you 50.0000 shares as per Hepion Pharmaceuticals Inc share price of $0.03 per share as on March 2, 2026 at 9:11 pm IST.

What is the minimum amount required to buy Hepion Pharmaceuticals Inc Stock (HEPA) from India?

Indian investors can start investing in Hepion Pharmaceuticals Inc (HEPA) shares with as little as ₹92.336 or $1 (as of April 9, 2026 at 3:34 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹923.36 in Hepion Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on April 9, 2026 at 3:34 am IST). Based on Hepion Pharmaceuticals Inc share’s latest price of $0.03 as on March 2, 2026 at 9:11 pm IST, you will get 333.3333 shares of Hepion Pharmaceuticals Inc. Learn more about fractional shares .